First report of an Aveir retrievable leadless pacemaker in a pediatric patient, via internal jugular vein access

Abstract

BackgroundThe Aveir device allows retrievability and mapping prior to fixation over alternative leadless pacemakers.Case summaryWe describe the first case of Aveir leadless pacemaker implantation into a 44.5 kg, pediatric patient with symptomatic sinus dysfunction. Access by the right internal jugular vein (RIJ) with 1st attempt implantation into the septal location.DiscussionPlacement of the Aveir leadless pacemaker is feasible in a 44.5 kg pediatric patient via a RIJ approach.

Aveir VR, retrievable leadless pacing in the young

“…There have only been two case reports of coil-based leadless pacemaker implantations in the ≦ 21-year-old population after it was first approved for clinical use in April of 2022 by the FDA. 5,6 The initial lim- Follow-up threshold 1.0V@0.2 ms 0.75V@0.2 ms 0.75V@0.2 ms 1V@0.2 ms 1.5V@0.4 ms 1.0V@0.2 ms 1.25V@0.2 ms 1.25@0.4 ms 0.75V@0.2 ms 0.5@0.2 ms Follow-up impedance itations of leadless pacemaker use in young patients were small size of veins for access and small interventricular septum size for implantation. However, there is supporting evidence of the achievability in implantation of the Micra leadless pacemaker in the pediatric population through the internal jugular vein.. 3,4 We demonstrate that even with the longer length of the Aveir VR device (38 mm), as compared to the Micra device (25.9 mm), a similar approach to IJ implantation can be performed from the right or left IJ.…”